X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10344) 10344
Magazine Article (20) 20
Book / eBook (2) 2
Book Review (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newsletter (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8645) 8645
imatinib mesylate (5887) 5887
benzamides (5135) 5135
pyrimidines - therapeutic use (4909) 4909
piperazines - therapeutic use (4833) 4833
male (4643) 4643
female (3775) 3775
antineoplastic agents - therapeutic use (3489) 3489
benzamides - therapeutic use (3012) 3012
middle aged (2947) 2947
animals (2900) 2900
adult (2683) 2683
oncology (2681) 2681
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2291) 2291
benzamides - pharmacology (2197) 2197
aged (2096) 2096
hematology (1717) 1717
imatinib (1682) 1682
treatment outcome (1660) 1660
protein kinase inhibitors - therapeutic use (1460) 1460
pharmacology & pharmacy (1443) 1443
mice (1387) 1387
chronic myelogenous leukemia (1206) 1206
piperazines - pharmacology (1182) 1182
pyrimidines - pharmacology (1139) 1139
chronic myeloid-leukemia (1084) 1084
cancer (1065) 1065
protein-tyrosine kinases - antagonists & inhibitors (1022) 1022
chronic myeloid leukemia (901) 901
leukemia, myelogenous, chronic, bcr-abl positive - genetics (894) 894
gastrointestinal stromal tumors - drug therapy (887) 887
pyrimidines - administration & dosage (839) 839
rats (826) 826
pyrimidines - adverse effects (823) 823
antineoplastic agents - pharmacology (822) 822
piperazines - administration & dosage (807) 807
dose-response relationship, drug (805) 805
piperazines - adverse effects (775) 775
mutation (762) 762
therapy (761) 761
drug resistance, neoplasm (758) 758
adolescent (741) 741
benzamides - administration & dosage (720) 720
care and treatment (718) 718
research (711) 711
cell line, tumor (705) 705
aged, 80 and over (671) 671
leukemia (664) 664
benzamides - adverse effects (653) 653
fusion proteins, bcr-abl - genetics (648) 648
expression (645) 645
bcr-abl (639) 639
prognosis (619) 619
mesylate (614) 614
leukemia, myelogenous, chronic, bcr-abl positive - pathology (602) 602
analysis (599) 599
drug therapy (599) 599
young adult (589) 589
antineoplastic agents - adverse effects (583) 583
apoptosis (574) 574
tyrosine kinase (569) 569
medicine & public health (560) 560
tyrosine kinase inhibitor (537) 537
antineoplastic agents (532) 532
dasatinib (532) 532
antineoplastic combined chemotherapy protocols - therapeutic use (523) 523
tumors (523) 523
time factors (520) 520
disease models, animal (517) 517
protein kinase inhibitors - pharmacology (510) 510
neurosciences (507) 507
clinical trials as topic (499) 499
resistance (480) 480
apoptosis - drug effects (474) 474
antimitotic agents (473) 473
gastrointestinal stromal tumors - pathology (467) 467
cell biology (459) 459
in-vitro (453) 453
health aspects (446) 446
activation (442) 442
c-kit (442) 442
biochemistry & molecular biology (434) 434
cml (433) 433
hemic and lymphatic diseases (432) 432
hematology, oncology and palliative medicine (428) 428
follow-up studies (422) 422
cell proliferation - drug effects (419) 419
enzyme inhibitors - therapeutic use (417) 417
inhibitor (417) 417
antineoplastic agents - administration & dosage (416) 416
proteins (414) 414
thiazoles - therapeutic use (412) 412
remission induction (406) 406
proto-oncogene proteins c-kit - genetics (404) 404
chemotherapy (403) 403
abridged index medicus (397) 397
cells (396) 396
efficacy (387) 387
benzamides - chemistry (380) 380
genetic aspects (380) 380
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9516) 9516
Japanese (264) 264
French (250) 250
Chinese (156) 156
German (143) 143
Russian (91) 91
Spanish (77) 77
Italian (65) 65
Polish (24) 24
Hungarian (17) 17
Dutch (12) 12
Portuguese (12) 12
Czech (9) 9
Danish (7) 7
Croatian (5) 5
Norwegian (5) 5
Swedish (5) 5
Hebrew (4) 4
Romanian (4) 4
Turkish (4) 4
Ukrainian (4) 4
Finnish (3) 3
Korean (3) 3
Bulgarian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 09/2015, Volume 113, Issue 5, pp. 931 - 942
Summary Several new anticoagulants have entered the clinical arena or are under clinical development. These drugs include indirect (fondaparinux) and direct... 
Review Article | Rivaroxaban | Antidotes | Dabigatran | New anticoagulants | Apixaban | ANDEXANET-ALPHA | VITAMIN-K ANTAGONISTS | rivaroxaban | apixaban | ATRIAL-FIBRILLATION | antidotes | IN-VITRO | ANTIIDIOTYPIC ANTIBODIES | PROTHROMBIN COMPLEX CONCENTRATE | ORAL ANTICOAGULANTS | MOLECULAR-WEIGHT HEPARIN | dabigatran | PERIPHERAL VASCULAR DISEASE | HEALTHY-VOLUNTEERS | HEMATOLOGY | ACUTE VENOUS THROMBOEMBOLISM | Recombinant Proteins - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Thrombosis - complications | Humans | Antibodies, Monoclonal - therapeutic use | Heparin - therapeutic use | Hemorrhage - prevention & control | Thiazoles - therapeutic use | Dabigatran - therapeutic use | Vitamin K - antagonists & inhibitors | Benzamides - therapeutic use | Anticoagulants - chemistry | Factor Xa - therapeutic use | Intracranial Hemorrhages - prevention & control | Rivaroxaban - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Hemostatics - chemistry | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Infusions, Parenteral | Clinical Trials as Topic | Factor Xa Inhibitors - therapeutic use | Animals | Protamines - therapeutic use | Pyridones - therapeutic use | Thrombosis - drug therapy | Hemorrhage - chemically induced | Hemostatics - therapeutic use
Journal Article
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 02/2008, Volume 15, Issue 5, pp. 422 - 432
...) for growth factors, are among the best targets for this type of therapeutic approach. Two classes of compounds targeting RTKs are currently used in clinical practice... 
Monoclonal antibodies | Small molecules | Tyrosine kinase receptors | Targeted therapy | Cancer therapy | Tyrosine kinase inhibitors | targeted therapy | CHEMISTRY, MEDICINAL | GROWTH-FACTOR-RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | BCR-ABL | MONOCLONAL-ANTIBODY | CHRONIC MYELOID-LEUKEMIA | tyrosine kinase inhibitors | CELL LUNG-CANCER | BREAST-CANCER | tyrosine kinase receptors | cancer therapy | PHASE-II TRIAL | IN-VIVO | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | GASTROINTESTINAL STROMAL TUMORS | small molecules | monoclonal antibodies | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Bevacizumab | Antibodies, Monoclonal, Humanized | Sunitinib | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Lapatinib | Cetuximab | Gefitinib | Pyrroles - therapeutic use | Pyridines - therapeutic use | Clinical Trials as Topic | Piperazines - therapeutic use | Enzyme Inhibitors - therapeutic use | Imatinib Mesylate | Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Sorafenib | Indoles - therapeutic use | Benzamides | Trastuzumab | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
BMC pulmonary medicine, ISSN 1471-2466, 2015, Volume 15, Issue 1, p. 145
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9971, pp. 857 - 866
Journal Article
Nature reviews. Endocrinology, ISSN 1759-5037, 2016, Volume 12, Issue 10, pp. 566 - 592
Journal Article
Journal Article